aspirin

Generic: aspirin

Labeler: target corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler target corporation
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
TARGET CORPORATION

Identifiers & Regulatory

Product NDC 11673-181
Product ID 11673-181_22771129-deba-e3a1-e063-6394a90a7e92
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2020-01-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673181
Hyphenated Format 11673-181

Supplemental Identifiers

RxCUI
308416
UPC
0349483481501
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (11673-181-12) / 120 TABLET, COATED in 1 BOTTLE
  • 500 TABLET, COATED in 1 BOTTLE (11673-181-50)
source: ndc

Packages (2)

11673-181-12 1 BOTTLE in 1 CARTON (11673-181-12) / 120 TABLET, COATED in 1 BOTTLE 11673-181-50 500 TABLET, COATED in 1 BOTTLE (11673-181-50)

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

ASPIRIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "22771129-deba-e3a1-e063-6394a90a7e92", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0349483481501"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["8ed252be-8fdb-3809-e053-2995a90a4b4f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-181-12)  / 120 TABLET, COATED in 1 BOTTLE", "package_ndc": "11673-181-12", "marketing_start_date": "20200101"}, {"sample": false, "description": "500 TABLET, COATED in 1 BOTTLE (11673-181-50)", "package_ndc": "11673-181-50", "marketing_start_date": "20200101"}], "brand_name": "ASPIRIN", "product_id": "11673-181_22771129-deba-e3a1-e063-6394a90a7e92", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "11673-181", "generic_name": "ASPIRIN", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200101", "listing_expiration_date": "20261231"}